BRIDGEBIO PHARMA INC NOTE 2.500% 3/1 is a security (CUSIP 10806XAB8) tracked across SEC portfolio filings. 45 institutional managers reported $868.3M on Form 13F as of 2026-06-30; 2 registered fund positions totaling $966K via N-PORT as of 2026-05-29.
Showing 15 of 45 managers by value.
| Manager | Location | Value | Shares |
|---|---|---|---|
| WOLVERINE ASSET MANAGEMENT LLC | CHICAGO, IL | $147.7M | 82,038,000 |
| STEELHEAD PARTNERS LLC | Seattle, WA | $126.6M | 70,000,000 |
| Linden Advisors LP | New York, NY | $105.3M | 58,430,000 |
| CAPSTONE INVESTMENT ADVISORS, LLC | NEW YORK, NY | $98.0M | 54,372,000 |
| Boussard & Gavaudan Investment Management LLP | London, X0 | $46.2M | 26,000 |
| MILLENNIUM MANAGEMENT LLC | NEW YORK, NY | $44.4M | 24,644,000 |
| Graham Capital Management, L.P. | ROWAYTON, CT | $40.1M | 22,241,000 |
| 683 Capital Management, LLC | NEW YORK, NY | $39.2M | 21,750,000 |
| ARISTEIA CAPITAL LLC | GREENWICH, CT | $33.3M | 18,500,000 |
| FMR LLC | BOSTON, MA | $28.4M | 15,807,000 |
| TENOR CAPITAL MANAGEMENT Co., L.P. | NEW YORK, NY | $27.1M | 15,000,000 |
| STATE STREET CORP | BOSTON, MA | $22.2M | 12,280,000 |
| M&G PLC | London, X0 | $21.1M | 11,879,000 |
| DeepCurrents Investment Group LLC | NEW YORK, NY | $17.1M | 9,500,000 |
| BlackRock, Inc. | New York, NY | $16.0M | 8,920,000 |
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| Franklin Alternative Strategies Fund | Franklin Alternative Strategies Funds | $959K | 16.28% |
| Virtus Global Multi-Sector Income Fund | Virtus Global Multi-Sector Income Fund | $6K | 0.71% |